Howard Strickler, M.D.
- Professor, Department of Epidemiology & Population Health (Epidemiology)
- Harold and Muriel Block Chair in Epidemiology & Population Health
Phone
Location
- Albert Einstein College of Medicine Jack and Pearl Resnick Campus 1300 Morris Park Avenue Belfer Building 1312A Bronx, NY 10461
Professional Interests
Howard D. Strickler, MD, MPH, is a Professor in the Department of Epidemiology & Population Health at Albert Einstein College of Medicine in New York City, where he is the Head of the Division of Epidemiology, and the Harold and Muriel Block Chair in Epidemiology. He is also leader of the Cancer Epidemiology Program of the Albert Einstein Cancer Center, as well as an Associate Director of the Clinical Core of the Center For AIDS Research (CFAR). He is internationally recognized for his work on HPV natural history in HIV+ women, which has played an important role in recent changes to the clinical guidelines for cervical cancer screening in women with HIV. His studies of obesity/inflammation and its relation with viral natural history and cancer risk have also been highly cited. Prior to Einstein in 1999, Dr. Strickler was a Senior Clinical Investigator for 7 years at NCI in the Division of Cancer Epidemiology and Genetics, which he joined after completing his MPH and residency in Preventive Medicine at Johns Hopkins. At the national level he has been a long term member of the USPHS/CDC/NIH task force (HPV disease section) to set clinical guidelines for disease prevention and treatment of adult HIV+ patients, and was a long term member of the NCI EPIC study section. He has several times received honors from NCI/NIH for his research regarding HPV and cervical disease among HIV+ women, as well as his other molecular (obesity) epidemiologic research, which have been cited as “Research Highlights” by the Epidemiology & Genomics Research Program of NCI.
Selected Publications
Gradíssimo A, Lam J, Attonito JD, Palefsky J, Massad LS, Xie X, Eltoum IE, Rahangdale L, Fischl MA, Anastos K, Minkoff H, Xue X, D'Souza G, Flowers LC, Colie C, Shrestha S, Hessol NA, Strickler HD*, Burk RD* (*dual senior authors). Methylation of High-Risk Human Papillomavirus Genomes are Associated with Cervical Precancer in HIV-positive Women. Cancer Epidemiol Biomarkers Prev. In Press.
Hosgood HD, Gunter MJ, Murphy N, Rohan TE, Strickler HD. The Relation of Obesity-Related Hormonal and Cytokine Levels With Multiple Myeloma and Non-Hodgkin Lymphoma. Front Oncol. 2018 Apr 16;8:103. doi: 10.3389/fonc.2018.00103. eCollection 2018. Review. PubMed PMID: 29713614; PubMed Central PMCID: PMC5911620.
Robbins HA, Strickler HD, Massad LS, Pierce CB, Darragh TM, Minkoff H, Keller MJ, Fischl M, Palefsky J, Flowers L, Rahangdale L, Milam J, Shrestha S, Colie C, DʼSouza G. Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS. 2017 Apr 24;31(7):1035-1044. doi:10.1097/QAD.0000000000001450. PubMed PMID: 28323758; PubMed Central PMCID: PMC5531443.
Xie X, Xue X, Strickler HD. Generalized linear mixed model for binary outcomes when covariates are subject to measurement errors and detection limits. Stat Med. 2018 Jan 15;37(1):119-136. PMCID: PMC5720942.
Nevadunsky NS, Van Arsdale A, Strickler HD, Spoozak LA, Moadel A, Kaur G, Girda E, Goldberg GL, Einstein MH. Association Between Statin Use and Endometrial Cancer Survival. Obstet Gynecol. [in press]
Xue X, Agalliu I, Kim MY, Wang T, Lin J, Ghavamian R, Strickler HD. New methods for estimating follow-up rates in cohort studies. BMC Med Res Methodol. 2017 Dec 1;17(1):155. doi: 10.1186/s12874-017-0436-z. PubMed PMID: 29191174;PubMed Central PMCID: PMC5709923.
Murphy N, Xu L, Zervoudakis A, Xue X, Kabat G, Rohan TE, Wassertheil-Smoller S, O'Sullivan MJ, Thomson C, Messina C, Strickler HD, Gunter MJ. Reproductive and menstrual factors and colorectal cancer incidence in the Women's Health Initiative Observational Study. Br J Cancer. 2017 Jan 3;116(1):117-125. doi:10.1038/bjc.2016.345. Epub 2016 Nov 29. PubMed PMID: 27898658; PubMed CentralPMCID: PMC5220139.
Reimers LL, Mehta SD, Massad LS, Burk RD, Xie X, Ravel J, Cohen MH, Palefsky JM, Weber KM, Xue X, Anastos K, Minkoff H, Atrio J, D'Souza G, Ye Q, Colie C, Zolnik CP, Spear GT, Strickler HD. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women. J Infect Dis. 2016;214:1361-1369. PMCID: PMC507936
Massad LS, Xie X, Burk RD, D'Souza G, Darragh TM, Minkoff H, Colie C, Burian P, Palefsky J, Atrio J, Strickler HD. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women. Am J Obstet Gynecol. 2016 Mar;214(3):354.e1-6. doi: 10.1016/j.ajog.2015.09.086. Epub 2015 Nov 14. PubMed PMID: 26433170; PubMed Central PMCID: PMC4775397
Keller MJ, Burk RD, Massad LS, Eltoum IE, Hessol NA, Castle PE, Anastos K, Xie X, Minkoff H, Xue X, D’Souza G, Flowers L, Levine AM, Colie C, Rahangdale L, Fischl MA, Palefsky JM, Strickler HD. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. Clin Infect Dis 2015, 15;61:1573-81.PMCID:PMC4614409
Gunter MJ, Xie X, Xue X, Kabat GC, Rohan TE, Wassertheil-Smoller S, Ho GY, Wylie-Rosett J, Greco T, Yu H, Beasley J, Strickler HD. Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Res. 2015, 75:270-4. PMCID:PMC4657855.
Agalliu I, Williams S, Adler B, Androga L, Siev M, Lin J, Xue X, Huang G, Strickler HD*, Ghavamian R* [*both senior authors contributed equally]. The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics. Cancer Causes Control. 2015, 26:821-30. PMCID:PMC498440
Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC, Scherer PE, Chlebowski RT, Snetselaar L, Wang D, Ho GY. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk. J Natl Cancer Inst. 2015, 107; PMCID: PMC4651104.
Xue X, Kim MY, Castle PE, Strickler H. A new method to address verification bias in studies of clinical screening tests: cervical cancer screening assays as an example. J Clin Epidemiol. 2014;67:343-53. PMCID: PMC3946800.
Keller MJ, Burk RD, Xie X, Anastos K, Massad LS, Minkoff H, Xue X, D'Souza G, Watts DH, Levine AM, Castle PE, Colie C, Palefsky JM, Strickler HD. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA. 2012 Jul 25;308(4):362-9. doi: 10.1001/jama.2012.5664. PMCID: PMC3556987.